In today’s pharmaceutical universe, a simple “safe and effective” determination by the Food and Drug Administration to approve a drug can be manipulated to sell products of questionable value. And drugmakers can profit handsomely.
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
If international scientific sleuths are hoping to see a lab log or find a whistleblower, that sort of information won’t be revealed. In China today, it is dangerous to say what you know if it challenges the official government narrative.
The pandemic has demonstrated that virtual medicine is great for simple visits. But many new types of telemedicine promoted by start-ups more clearly benefit providers’ and investors’ pockets, rather than yielding more convenient, high-quality and cost-effective medicine for patients.
The United States has undergone a cultural, definitional, practical shift on guns and what they are for.
After 9/11, as our defenses against international and bioterrorism hardened, our defenses against infectious diseases shrank. By the time a deadly virus arrived on our shores last year, nearly two-thirds of Americans were living in counties that spend more than twice as much on policing as they spend on public health.
President Joe Biden may want to continue the previous administration’s efforts to lower drug prices and make medical costs transparent.
Living through SARS taught my children important lessons, and not just about hygiene. It taught them how to make sacrifices for the sake of friends, family and community.
When hospital administrators and politicians’ spouses get immunized before people more at risk, it undermines confidence in the system.
There are already signs that the distribution of the COVID vaccines will be messy, confusing and chaotic.